相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。α1-Antitrypsin Phenotypes and Associated Serum Protein Concentrations in a Large Clinical Population
Joshua A. Bornhorst et al.
CHEST (2013)
The Challenge of Detecting Alpha-1 Antitrypsin Deficiency
James K. Stoller et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Alpha-1 Antitrypsin Deficiency: The European Experience
Robert A. Stockley et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
How Patients Learned to Control Their Own Future
John W. Walsh
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Inhaled Alpha 1-Antitrypsin: Gauging Patient Interest in a New Treatment
Richard Monk et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Introduction to the 50th Anniversary of the Description of Alpha-1 Antitrypsin Deficiency
Robert A. Sandhaus et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Gene-Based Therapy for Alpha-1 Antitrypsin Deficiency
Christian Mueller et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Airway Disease in Alpha-1 Antitrypsin Deficiency
Charlie Strange
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Understanding and Future Therapy
Jeffrey H. Teckman
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Outcomes for Recipients of Liver Transplantation for Alpha-1-Antitrypsin Deficiency-Related Cirrhosis
Elizabeth J. Carey et al.
LIVER TRANSPLANTATION (2013)
Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase
Danny Jonigk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis
Jose Maria Hernandez Perez et al.
RHEUMATOLOGY (2013)
A Review of α1-Antitrypsin Deficiency
James K. Stoller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: A Canadian Thoracic Society clinical practice guideline
D. D. Marciniuk et al.
CANADIAN RESPIRATORY JOURNAL (2012)
Novel Therapeutic Uses of Alpha-1 Antitrypsin: A Window to the Future
Adam Wanner et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method
Ignacio Blanco et al.
HEPATITIS MONTHLY (2012)
Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells
David Ross et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Expanding the Clinical Indications for α1-Antitrypsin Therapy
Eli C. Lewis
MOLECULAR MEDICINE (2012)
Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent
Donald E. Schmechel et al.
NEUROTOXICOLOGY (2012)
Gene Therapy Meets Stem Cells
Robert A. Sandhaus
NEW ENGLAND JOURNAL OF MEDICINE (2012)
SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA Cohort
Gian-Andri Thun et al.
PLOS ONE (2012)
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
Isao Tawara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank
Adriano Tonelli
International Journal of Chronic Obstructive Pulmonary Disease (2012)
Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy
Juan Carlos Barros-Tizon et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)
Rare alpha-1-antitrypsin variants: are they really so rare?
Francisco Rodriguez-Frias et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)
Prevalence of a1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review
Frederick J. de Serres et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)
Oxidation of Z α1-Antitrypsin by Cigarette Smoke Induces Polymerization A Novel Mechanism of Early-Onset Emphysema
Sam Alam et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
ANCA-associated vasculitis is linked to carriage of the Z allele of α1 antitrypsin and its polymers
H. Morris et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model
A. Mario Marcondes et al.
BLOOD (2011)
Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury
Stefano Toldo et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: Remission induced and maintained with intravenous alpha 1-antitrypsin
Firas Al-Niaimi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model
Christian Grimstein et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
α-1-Antitrypsin Gene Delivery Reduces Inflammation, Increases T-Regulatory Cell Population Size and Prevents Islet Allograft Rejection
Galit Shahaf et al.
MOLECULAR MEDICINE (2011)
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
Kosuke Yusa et al.
NATURE (2011)
Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema
Ignacio Blanco et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
The discovery of α1-antitrypsin and its rote in health and disease
Sabina M. Janciauskiene et al.
RESPIRATORY MEDICINE (2011)
Accelerated Spirometric Decline in New York City Firefighters With α1-Antitrypsin Deficiency
Gisela I. Banauch et al.
CHEST (2010)
α1-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts
Inga-Cecilie Sorheim et al.
CHEST (2010)
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients
Ignacio Blanco et al.
CLINICAL RHEUMATOLOGY (2010)
Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model
Shalesh Kaushal et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
David A. Bergin et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis
Christian Grimstein et al.
JOURNAL OF GENE MEDICINE (2010)
Alpha(sub 1)-Antitrypsin Deficiency and Autophagy.
Stefan J. Marciniak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Defining the mechanism of polymerization in the serpinopathies
Ugo I. Ekeowa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
An Autophagy-Enhancing Drug Promotes Degradation of Mutant α1-Antitrypsin Z and Reduces Hepatic Fibrosis
Tunda Hidvegi et al.
SCIENCE (2010)
Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide
Wolf-Georg Forssmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells
Martins Kalis et al.
ISLETS (2010)
Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America
Frederick J. de Serres et al.
Therapeutic Advances in Respiratory Disease (2010)
Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry
Robert A. Stockley et al.
RESPIRATORY RESEARCH (2010)
Augmentation Therapy for α1 Antitrypsin Deficiency: A Meta-Analysis
Kenneth R. Chapman et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009)
Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency
A. Dirksen et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Safety/Efficacy of Inhaled Human Alpha-1 Antitrypsin (AAT) in CF: A Phase II Clinical Study
E. Kerem et al.
Journal of Cystic Fibrosis (2009)
α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
Gregory B. Pott et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
Mark L. Brantly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals
Elisabeth Bernspang et al.
RESPIRATORY MEDICINE (2009)
IL10 polymorphisms are associated with airflow obstruction in severe alpha(1)-antitrypsin deficiency
Dawn L. DeMeo et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Prevalence and impact of bronchiectasis in α1-antitrypsin deficiency
David G. Parr et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide
Jan Muench et al.
CELL (2007)
Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development
R. A. Stockley et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
α1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
M. Griese et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma - Results from the ALA-ACRC low-dose theophylline trial
E. Eden et al.
JOURNAL OF ASTHMA (2007)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 α1-antitrypsin (AAT) vector in AAT-deficient adults
Mark L. Brantly et al.
HUMAN GENE THERAPY (2006)
α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis
Irina Petrache et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
An official ATS statement:: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations
Holger J. Schuenemann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1
LF Congote
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Safety and efficacy of recombinant alpha1-antitrypsin therapy in cystic fibrosis
SL Martin et al.
PEDIATRIC PULMONOLOGY (2006)
Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha-antitrypsin deficiency in European countries
I Blanco et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Grading strength of recommendations and quality of evidence in clinical guidelines - Report from an American College of Chest Physicians task force
G Guyatt et al.
CHEST (2006)
Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use
E. Karnaukhova et al.
AMINO ACIDS (2006)
Aggrecanase-1 (ADAMTS-4) interacts with α1-antitrypsin
K Yoshida et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
α1-antitrypsin monotherapy prolongs islet allograft survival in mice
EC Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The protease inhibitor PI*S allele and COPD: a meta-analysis
M Dahl et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Glutathione S-transferase P1 and lung function in patients with α1-antitrypsin deficiency and COPD
F Rodriguez et al.
CHEST (2005)
Polymers of Z α1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo
R Mahadeva et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
α1-Antitrypsin deficiency • 1:: Epidemiology of α1-antitrypsin deficiency
M Luisetti et al.
THORAX (2004)
Chronic obstructive pulmonary disease in α1-antitrypsin PI MZ heterozygotes:: a meta-analysis
CP Hersh et al.
THORAX (2004)
Application of transgenesis in livestock for agriculture and biomedicine
H Niemann et al.
ANIMAL REPRODUCTION SCIENCE (2003)
American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Augmentation therapy with α1-antitrypsin -: Patterns of use and adverse events
JK Stoller et al.
CHEST (2003)
α1-Antitrypsin:: Not just an antiprotease -: Extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol
M Brantly
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Polyethylene glycol conjugation at Cys232 prolongs the half-life of α1 proteinase inhibitor
AM Cantin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Worldwide racial and ethnic distribution of α1-antitrypsin deficiency -: Summary of an analysis of published genetic epidemiologic surveys
FJ de Serres
CHEST (2002)
The effect of augmentation therapy on bronchial inflammation in α1-antitrypsin deficiency
RA Stockley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles
S Janciauskiene
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2001)
Longitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitor
M Wencker et al.
CHEST (2001)
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1
L Shapiro et al.
FASEB JOURNAL (2001)
Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency - A new hypothesis with supporting data
J Lieberman
CHEST (2000)
Molecular mechanisms of alpha1-antitrypsin null alleles
JH Lee et al.
RESPIRATORY MEDICINE (2000)
Transfection of nasal mucosa with a normal α1-antitrypsin gene in α1-antitrypsin-deficient subjects:: Comparison with protein therapy
KL Brigham et al.
HUMAN GENE THERAPY (2000)
The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo
Z Liu et al.
CELL (2000)
Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ
N Seersholm et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
